September 12, 2022
Gilead Sciences Inc. has settled its Delaware patent infringement lawsuit against five generic-drug makers on the eve of trial, inking a deal that calls for the delayed release until at least 2031 of generic alternatives to Gilead's line of medications that slow the progress of HIV infections.
September 08, 2022
The D.C. Circuit next week will consider a long-simmering constitutional challenge to parts of the Digital Millennium Copyright Act that lawyers at the Electronic Frontier Foundation call "a draconian federal statute that directly restricts [the] ability to speak." Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.